A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

Clinical trial NCT07647510 · RECRUITING

Trial details

NCT number: NCT07647510
Sponsor: Dianthus Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Myasthenia Gravis, Generalized

Start date: 2026-07-01
Primary completion: 2028-12-01
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.